|
|
||||||||
Oak Ridge Poster Sessions |
1
Helena Labs., Beaumont, TX;
a author for
correspondence: fax 409-772-9231
Hemoglobin is composed of two
and two ß polypeptide
chains. Any modifications in the amino acid sequence, which may either
be congenital or acquired, affects the oxygen-carrying ability of
hemoglobin, resulting in a series of hemoglobinopathies. To date, >600
structurally different human hemoglobins are known
(1)(2). Identification of abnormal hemoglobin
is very important in the differential diagnosis of hemoglobinopathies.
Currently, most clinical laboratories have a battery of hemoglobin
assays that includes gel electrophoresis, ion-exchange or affinity
chromatography, and isoelectric focusing
(1)(3). Of all the available methods,
computer-operated cation-exchange HPLC is the most widely used for
identifying and quantifying major and minor hemoglobins
(4)(5)(6)(7). The main disadvantage of a HPLC system is
expensive instrumentation and the high cost of columns and reagents.
Although an excellent resolution is achieved with gel isoelectric
focusing (8), it is labor intensive, time consuming, and
not readily amenable for routine screening.
The use of capillary electrophoresis (CE) for identification of hemoglobin variants has been reported by several authors (9)(10)(11)(12). In 1994, Hempe and Craver demonstrated the applicability of CE for quantification and identification of hemoglobin variants in clinical samples (13). Capillary isoelectric focusing (cIEF) was performed on a dimethylpolysiloxane (DMS)-coated fused silica capillary having an i.d. of 50 µm. The method is rapid, requires low sample volume, and gives excellent resolution for all major and most of the minor hemoglobin variants. The main drawback of this method is the use of DMS-coated capillary. In our laboratory we found that coated capillaries are not very stable and show considerable lot-to-lot variation, thereby resulting in irreproducible migration times. cIEF can also be done on a fused silica capillary provided electroosmotic flow (EOF) is eliminated or reduced. This can be achieved by addition of hydrophilic polymers such as methyl cellulose (MC) (11). MC (2 g/L) reduces EOF significantly but not to the extent seen in a neutral DMS-coated capillary, thus resulting in poor precision for migration times.
We have overcome this problem of irreproducible migration time on a fused silica capillary by introducing two external pI markers purchased from Bio-Rad bracketing the pI gradient 6.6 and 7.7 formed by the ampholine (pI 6.67.7). The cIEF is performed on a 57 cm x 50 µm (i.d.) fused silica capillary. The electrophoresis is performed on a PrinCE system manufactured by Helena Labs., and data evaluation was done on Ceaser software. NaOH (20 mmol/L) and H3PO4 (100 mmol/L) constituted catholyte and anolyte solutions, respectively. The run buffer consisted of 50 mL/L ampholine prepared in 3 g/L MC solution. Sample preparation involved dilution of 50 µL of citrated whole blood to 1 mL with hemolyzing reagent (10 mmol EDTA and 5 mmol KCN). Two-hundred microliters of hemolyzed blood is further diluted to 400 µL with 2 g/L MC containing 30 mL/L ampholine and 2 µL of individual pI markers (1 g/L). Before focusing, the capillary is flushed with run buffer for 1 min at 200 kPa (2000 mbar) pressure. A sample plug is injected for 0.4 min at 20 kPa (200 mbar) pressure, followed by injection of run buffer at 20 kPa (200 mbar) pressure for 0.4 min. Focusing is carried out at 30 kV for 5 min and separated hemoglobin variants are mobilized past the detector window by applying low pressure [8 kPa (80 mbar)] under an applied voltage of 30 kV.
Figure 1
shows the separation of the four most common hemoglobin
variants (C, S, F, and A). The pI marker 7.7, being most alkaline,
migrates first and the pI marker 6.6 is seen last. These two markers
define the beginning and end of the pH gradient. We overcame the
problem of irreproducible migration times on fused silica capillaries
by relating the migration times of the individual hemoglobins to these
two markers. This is done by defining a new term called migration
index, which is the ratio of the distance of a hemoglobin variant from
two markers and is calculated as shown in Eq. 1
:
![]() | (1) |
|
|
Footnotes
Clin. Chem. Div., Dept. of Pathol., Univ. of TexasMedical Branch, Galveston, TX 77555-0551
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |